Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001359820-11-000002

CEO bought 4,600 shares at $1.16 ($5,342)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Babcock Dwight William CEO 2011-03-08 Purchase +4,600 $1.16 $5,342 156,273 D
Open-market purchases · 4,600 sh · avg $1.16 · $5,342
Loading xslF345X03/primary_doc.xml…